The Peptide Field
Menu

Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Narrow the list

Filters

Showing 41–60 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

41
Randomized trialPubMed · New England Journal of Medicine · 2023Checked 2026-07-23

Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial

Reviews using this sourceRetatrutide
Open source
42
Randomized trialPubMed · Nature Medicine · 2024Checked 2026-07-23

Retatrutide for metabolic dysfunction-associated steatotic liver disease

Reviews using this sourceRetatrutide
Open source
43
Trial registryClinicalTrials.gov · 2026Checked 2026-07-23

TRIUMPH-1 phase 3 study record

Reviews using this sourceRetatrutide
Open source
44
Trial registryClinicalTrials.gov · 2026Checked 2026-07-23

TRIUMPH-2 phase 3 study record

Reviews using this sourceRetatrutide
Open source
45
Trial registryClinicalTrials.gov · 2026Checked 2026-07-23

TRIUMPH-3 phase 3 study record

Reviews using this sourceRetatrutide
Open source
46
ReferenceEli Lilly and Company · 2026Checked 2026-07-24

TRIUMPH-1 early sponsor-reported results

Reviews using this sourceRetatrutide
Open source
47
ReferenceEli Lilly and Company · 2026Checked 2026-07-24

TRIUMPH-2 and TRIUMPH-3 early sponsor-reported results

Reviews using this sourceRetatrutide
Open source
48
Randomized trialPubMed · The Lancet · 2021Checked 2026-08-30

Cagrilintide for weight management: randomized phase 2 trial

Reviews using this sourceCagrilintide
Open source
49
Randomized trialPubMed · New England Journal of Medicine · 2025Checked 2026-08-30

Coadministered cagrilintide and semaglutide in adults with overweight or obesity

Reviews using this sourceCagrilintide
Open source
50
Trial registryClinicalTrials.gov · 2026Checked 2026-08-30

Cagrilintide clinical study record

Reviews using this sourceCagrilintide
Open source
51
Trial registryClinicalTrials.gov · 2021Checked 2026-08-30

Phase 2 cagrilintide study record (NNC0174-0833)

Reviews using this sourceCagrilintide
Open source
52
PreclinicalPubMed · Journal of Pharmacology and Experimental Therapeutics · 2021Checked 2026-08-30

AM833 pharmacology and cagrilintide identity

Reviews using this sourceCagrilintide
Open source
53
PreclinicalPubMed · Journal of Medicinal Chemistry · 2021Checked 2026-08-30

Development of Cagrilintide, a Long-Acting Amylin Analogue

Reviews using this sourceCagrilintide
Open source
54
Human pharmacologyPubMed · The Lancet · 2021Checked 2026-08-30

Cagrilintide with semaglutide: human exposure and effects

Reviews using this sourceCagrilintide
Open source
55
ReferenceNovo Nordisk · 2026Checked 2026-08-30

Q2 2026 research pipeline: NN9833 is cagrilintide

Reviews using this sourceCagrilintide
Open source
56
ReferenceU.S. Food and Drug Administration · 2026Checked 2026-08-30

FDA substance record: cagrilintide identity (not an approval record)

Reviews using this sourceCagrilintide
Open source
57
ReferenceU.S. Food and Drug Administration · 2026Checked 2026-08-30

FDA identity record for elamipretide and SS-31

Reviews using this sourceSS-31
Open source
58
RegulatoryU.S. Food and Drug Administration · 2025Checked 2026-08-30

FDA grants accelerated approval to Forzinity for Barth syndrome

Reviews using this sourceSS-31
Open source
59
FDA reviewU.S. Food and Drug Administration · 2025Checked 2026-08-30

Forzinity Drug Trials Snapshot

Reviews using this sourceSS-31
Open source
60
Drug labelU.S. Food and Drug Administration · 2025Checked 2026-08-30

Forzinity prescribing information

Reviews using this sourceSS-31
Open source

About this list

How this list works

This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.